GMTX Stock Price, News & Analysis
Company Description
GMTX (NASDAQ: GMTX) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector. The company has a market capitalization of $58.5M.
GMTX stock has declined 53.1% over the past year.
This page provides a comprehensive overview of GMTX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
GMTX (GMTX) stock. Over the past 12 months, the stock has lost 53.1%. At a market capitalization of $58.5M, GMTX is classified as a micro-cap stock.
Latest News
GMTX has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 4 with negative movement. Key topics include clinical trial, fda approval, acquisition, earnings, conferences. View all GMTX news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
GMTX Company Profile & Sector Positioning
GMTX (GMTX) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.